ethicor pharma ltd Company Information
Company Number
07984924
Next Accounts
2198 days late
Shareholders
richard drury
robert jackson
View AllGroup Structure
View All
Industry
Wholesale of pharmaceutical goods
Registered Address
24 - 25 new bond street, first floor, london, W1S 2RR
Website
ethicorpharma.comethicor pharma ltd Estimated Valuation
Pomanda estimates the enterprise value of ETHICOR PHARMA LTD at £263k based on a Turnover of £841k and 0.31x industry multiple (adjusted for size and gross margin).
ethicor pharma ltd Estimated Valuation
Pomanda estimates the enterprise value of ETHICOR PHARMA LTD at £6.3m based on an EBITDA of £2m and a 3.16x industry multiple (adjusted for size and gross margin).
ethicor pharma ltd Estimated Valuation
Pomanda estimates the enterprise value of ETHICOR PHARMA LTD at £0 based on Net Assets of £-886.7k and 1.92x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Ethicor Pharma Ltd Overview
Ethicor Pharma Ltd is a live company located in london, W1S 2RR with a Companies House number of 07984924. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in March 2012, it's largest shareholder is richard drury with a 23% stake. Ethicor Pharma Ltd is a established, small sized company, Pomanda has estimated its turnover at £841k with high growth in recent years.
Upgrade for unlimited company reports & a free credit check
Ethicor Pharma Ltd Health Check
Pomanda's financial health check has awarded Ethicor Pharma Ltd a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 5 measures and has 5 areas for improvement. Company Health Check FAQs


5 Strong

2 Regular

5 Weak

Size
annual sales of £841k, make it smaller than the average company (£18.9m)
- Ethicor Pharma Ltd
£18.9m - Industry AVG

Growth
3 year (CAGR) sales growth of 23%, show it is growing at a faster rate (6.5%)
- Ethicor Pharma Ltd
6.5% - Industry AVG

Production
with a gross margin of 12.3%, this company has a higher cost of product (26.6%)
- Ethicor Pharma Ltd
26.6% - Industry AVG

Profitability
an operating margin of 235.8% make it more profitable than the average company (3.3%)
- Ethicor Pharma Ltd
3.3% - Industry AVG

Employees
with 1 employees, this is below the industry average (39)
- Ethicor Pharma Ltd
39 - Industry AVG

Pay Structure
on an average salary of £57.4k, the company has an equivalent pay structure (£57.4k)
- Ethicor Pharma Ltd
£57.4k - Industry AVG

Efficiency
resulting in sales per employee of £841k, this is more efficient (£514k)
- Ethicor Pharma Ltd
£514k - Industry AVG

Debtor Days
it gets paid by customers after 48 days, this is earlier than average (61 days)
- Ethicor Pharma Ltd
61 days - Industry AVG

Creditor Days
its suppliers are paid after 229 days, this is slower than average (31 days)
- Ethicor Pharma Ltd
31 days - Industry AVG

Stock Days
it holds stock equivalent to 57 days, this is in line with average (57 days)
- Ethicor Pharma Ltd
57 days - Industry AVG

Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (9 weeks)
0 weeks - Ethicor Pharma Ltd
9 weeks - Industry AVG

Debt Level
it has a ratio of liabilities to total assets of 487.6%, this is a higher level of debt than the average (60.8%)
487.6% - Ethicor Pharma Ltd
60.8% - Industry AVG
ETHICOR PHARMA LTD financials

Ethicor Pharma Ltd's latest turnover from June 2017 is estimated at £841 thousand and the company has net assets of -£886.7 thousand. According to their latest financial statements, we estimate that Ethicor Pharma Ltd has 1 employee and maintains cash reserves of £168 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | |
---|---|---|---|---|---|
Turnover | |||||
Other Income Or Grants | |||||
Cost Of Sales | |||||
Gross Profit | |||||
Admin Expenses | |||||
Operating Profit | |||||
Interest Payable | |||||
Interest Receivable | |||||
Pre-Tax Profit | |||||
Tax | |||||
Profit After Tax | |||||
Dividends Paid | |||||
Retained Profit | |||||
Employee Costs | |||||
Number Of Employees | |||||
EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | |
---|---|---|---|---|---|
Tangible Assets | 1,782 | 1,781 | 2,323 | 283 | |
Intangible Assets | |||||
Investments & Other | |||||
Debtors (Due After 1 year) | |||||
Total Fixed Assets | 1,782 | 1,781 | 2,323 | 283 | |
Stock & work in progress | 116,087 | 116,088 | 116,088 | 10,042 | |
Trade Debtors | 110,718 | 92,439 | 93,509 | 105,613 | 99,934 |
Group Debtors | |||||
Misc Debtors | |||||
Cash | 168 | 1,507 | 42 | 2,317 | 85,930 |
misc current assets | |||||
total current assets | 226,973 | 210,034 | 209,639 | 117,972 | 185,864 |
total assets | 228,755 | 210,034 | 211,420 | 120,295 | 186,147 |
Bank overdraft | |||||
Bank loan | |||||
Trade Creditors | 463,395 | 314,819 | 262,461 | 162,581 | 385,282 |
Group/Directors Accounts | |||||
other short term finances | |||||
hp & lease commitments | |||||
other current liabilities | |||||
total current liabilities | 463,395 | 314,819 | 262,461 | 162,581 | 385,282 |
loans | |||||
hp & lease commitments | |||||
Accruals and Deferred Income | |||||
other liabilities | 652,019 | 463,394 | 241,808 | 81,121 | |
provisions | 167,076 | ||||
total long term liabilities | 652,019 | 630,470 | 241,808 | 81,121 | |
total liabilities | 1,115,414 | 945,289 | 504,269 | 243,702 | 385,282 |
net assets | -886,659 | -735,255 | -292,849 | -123,407 | -199,135 |
total shareholders funds | -886,659 | -735,255 | -292,849 | -123,407 | -199,135 |
Jun 2017 | Jun 2016 | Jun 2015 | Jun 2014 | Jun 2013 | |
---|---|---|---|---|---|
Operating Activities | |||||
Operating Profit | |||||
Depreciation | 873 | 790 | 47 | ||
Amortisation | |||||
Tax | |||||
Stock | -1 | 106,046 | 10,042 | ||
Debtors | 18,279 | -1,070 | -12,104 | 5,679 | 99,934 |
Creditors | 148,576 | 52,358 | 99,880 | -222,701 | 385,282 |
Accruals and Deferred Income | |||||
Deferred Taxes & Provisions | -167,076 | 167,076 | |||
Cash flow from operations | |||||
Investing Activities | |||||
capital expenditure | |||||
Change in Investments | |||||
cash flow from investments | |||||
Financing Activities | |||||
Bank loans | |||||
Group/Directors Accounts | |||||
Other Short Term Loans | |||||
Long term loans | |||||
Hire Purchase and Lease Commitments | |||||
other long term liabilities | 188,625 | 221,586 | 160,687 | 81,121 | |
share issue | |||||
interest | |||||
cash flow from financing | |||||
cash and cash equivalents | |||||
cash | -1,339 | 1,465 | -2,275 | -83,613 | 85,930 |
overdraft | |||||
change in cash | -1,339 | 1,465 | -2,275 | -83,613 | 85,930 |
ethicor pharma ltd Credit Report and Business Information
Ethicor Pharma Ltd Competitor Analysis

Perform a competitor analysis for ethicor pharma ltd by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other small companies, companies in W1S area or any other competitors across 12 key performance metrics.
ethicor pharma ltd Ownership
ETHICOR PHARMA LTD group structure
Ethicor Pharma Ltd has no subsidiary companies.
Ultimate parent company
ETHICOR PHARMA LTD
07984924
ethicor pharma ltd directors
Ethicor Pharma Ltd currently has 6 directors. The longest serving directors include Mr Robert Jackson (Mar 2012) and Mr Richard Drury (Mar 2012).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Robert Jackson | 69 years | Mar 2012 | - | Director | |
Mr Richard Drury | 75 years | Mar 2012 | - | Director | |
Mr Timothy Tickner | England | 57 years | Jul 2013 | - | Director |
Dr Malvin Eutick | England | 75 years | Jan 2015 | - | Director |
Mr Sanford Simon | England | 93 years | Feb 2015 | - | Director |
Mr Kelechi Edomobi | England | 49 years | Sep 2015 | - | Director |
P&L
June 2017turnover
841k
+28%
operating profit
2m
0%
gross margin
12.4%
-7.54%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
June 2017net assets
-886.7k
+0.21%
total assets
228.8k
+0.09%
cash
168
-0.89%
net assets
Total assets minus all liabilities
ethicor pharma ltd company details
company number
07984924
Type
Private limited with Share Capital
industry
46460 - Wholesale of pharmaceutical goods
incorporation date
March 2012
age
13
incorporated
UK
ultimate parent company
accounts
Unaudited Abridged
last accounts submitted
June 2017
previous names
N/A
accountant
-
auditor
-
address
24 - 25 new bond street, first floor, london, W1S 2RR
Bank
-
Legal Advisor
-
ethicor pharma ltd Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to ethicor pharma ltd.
ethicor pharma ltd Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ETHICOR PHARMA LTD. This can take several minutes, an email will notify you when this has completed.
ethicor pharma ltd Companies House Filings - See Documents
date | description | view/download |
---|